Transplantation of Isl1 + cardiac progenitor cells in small intestinal submucosa improves infarcted heart function

Background Application of cardiac stem cells combined with biomaterial scaffold is a promising therapeutic strategy for heart repair after myocardial infarction. However, the optimal cell types and biomaterials remain elusive.